Curriculum vitae

Frank P. Leu, Ph.D.

Biotechnology strategist, molecular biologist, pharmacologist, founder, advisor, educator, and speaker focused on translational science, drug development, research operations, and trusted digital systems for biopharma.

Download CV
Career map showing research, venture, advisory, education, and digital biopharma milestones.
Career arc from molecular pharmacology and antibody therapeutics to venture formation, advisory work, and AI/blockchain leadership in biopharma.
20+Years across biotech, academia, and advisory work
60+Speaking, chair, moderator, and facilitator roles
8Peer-reviewed scientific publications
3Patent-related therapeutic programs

Professional summary

Biotech strategy grounded in science, operations, and funding execution.

Frank Leu brings more than two decades of experience guiding pre-award research operations, proposal development, interdisciplinary funding strategies, technology partnerships, and drug development planning across biotech, academic, and government-facing environments.

His work spans molecular biology, enzymology, pharmacology, antibody therapeutics, venture formation, SBIR funding, sponsored research administration, strategic alliances, faculty research support, and the practical use of AI and blockchain in life sciences.

Explore

Search and filter the CV.

Experience

Founder, advisor, research scientist, educator, and translational operator.

Education and certifications

Formal training plus continuing digital biopharma credentials.

Credentials

Blockchain and emerging technology training.

Leadership and recognition

Conference leadership, award recognition, mentoring, and advisory roles.

Leadership

Accolades

Speaking archive

AI, blockchain, clinical trials, drug discovery, supply chain, and biotech entrepreneurship.

Publications and IP

Peer-reviewed research, patent-related work, and industry writing.

Memberships

Scientific, clinical, and life science networks.

Expertise

Operational and technical domains.

Contact

Available for biotech strategy, translational research, venture, sponsored research, and digital biopharma advisory conversations.